3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
6
Terminated
3
Withdrawn
1
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Renal Cell
14
Neoplasm Metastasis
6
Kidney Neoplasms
5
Breast Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Glioblastoma
3
Urinary Bladder Neoplasms
2
Prostatic Neoplasms
2
Neoplasms
2
Uveal Melanoma
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Ovarian Neoplasms
1
Lung Neoplasms
1
Hormone Refractory Prostate Cancer
1
Glioma
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Fatigue
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma
1
Carcinoid Tumor
1
Brain Neoplasms
1
Interventions
Fluorouracil
80
Oxaliplatin
72
Leucovorin
66
Irinotecan
60
Capecitabine
58
Bevacizumab
57
Cetuximab
43
Folfox protocol
22
Drug Therapy
22
Neoadjuvant Therapy
19
HMPL-013
17
Colonoscopy
17
regorafenib
15
apatinib
11
Panitumumab
11
Chemotherapy, Adjuvant
11
trifluridine tipiracil drug combination
10
XELOX
10
Laparoscopy
10
IFL protocol
10
sintilimab
9
raltitrexed
9
Radiotherapy
9
Blood Specimen Collection
9
Surveys and Questionnaires
8
Surgical Procedures, Operative
8
tislelizumab
7
pembrolizumab
7
Endoscopic Mucosal Resection
7
Aspirin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Colorectal Neoplasms
×
Sunitinib
×
Clear all
NCT03909724
2020-11-13
SUNRISE-CRC
Amsterdam UMC, location VUmc
Phase 2/3
Unknown
60 enrolled